2016 Hematological Malignancies

Treatment-Related Serious Adverse Events

Adverse Event, n (%)

cHL

(n = 23)

Any Grade

Grade 3–4

Any event

3 (13)

2 (9)

Lymph node pain

1 (4)

0 (0)

Pancreatitis

1 (4)

Myelodysplastic syndrome

1 (4)

•

3 patients discontinued due to adverse events

–

2 discontinuations were study drug related (pancreatitis, myelodysplastic syndrome)